Prognostic factors in hospitalized patients diagnosed with SARS-CoV-2 infection, Bogotá, Colombia
Abstract
Introduction: Infection with the new SARS-Cov-2 coronavirus is a worldwide public health emergency; its diagnosis is based on molecular tests, while its prognosis depends on the patient’s history and on some paraclinical tests. In Colombia, forecasts are not yet counted.
Objective: To assess the factors associated with the development of severe disease in hospitalized patients diagnosed with SARS-CoV-2 infection, as well as the prognostic factors for the outcome of mortality.
Materials and methods: We conducted an ambispective cohort study in hospitalized patients at the Fundación Cadioinfantil from March to June, 2020.
Results: Of the 104 patients analyzed, 31.7% (n=33) had a severe presentation and 9.6% (n=10) had a mortality outcome. For mortality, the most important prognostic factor was the development of severe disease followed by age over 60 years and malnutrition. For the development of the severe disease, prognostic factors were a history of hemodialysis (HR=135), diabetes (HR=4.4), and an increased level of lactate dehydrogenase (LDH) (HR=1,004), while the lymphocyte count over 1,064 was a protective factor (HR=0.9). In the classification of patients, the National Early Warning Score (NEWS2) score in the high and low-risk categories corresponded to the best performance. There was no difference between the treatments administered.
Conclusions: The most important prognostic factors for mortality were being over 60 years of age, hypertension, diabetes, and cirrhosis, while for the development of severe disease they were chronic kidney disease with hemodialysis, NEWS2 with high risk at admission, increased levels of LDH and C reactive protein (CRP), and leukocytosis.
Downloads
References
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-20. https://doi.org/10.1056/NEJMoa2002032
World Health Organization. Coronavirus disease (COVID-19). Situation report - Weekly Epidemiological Update. Fecha de consulta: 16 de septiembre de 2020. Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200914-weeklyepi-update-5.pdf?sfvrsn=cf929d04_2
Instituto Nacional Salud. Coronavirus (COVID-19) en Colombia. Fecha de consulta: 16 de septiembre de 2020. Disponible en: https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx
Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species of severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536-44. https://doi.org/10.1038/s41564-020-0695-z
Koichi Y, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. 2020;215:108427. https://doi.org/10.1016/j.clim.2020.108427
Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents. 2020;5105955. https://doi.org/10.1016/j.ijantimicag.2020.105955
Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181-92. https://doi.org/10.1038/s41579-018-0118-9
Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363-74. https://doi.org/10.1038/s41577-020-0311-8
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934-43. https://doi.org/10.1001/jamainternmed.2020.0994
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-9. https://doi.org/10.1001/jama.2020.1585
Wang L, Wang Y, Ye D, Liu Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents. 2020;55:105948. https://doi.org/10.1016/j.ijantimicag.2020.105948
Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical characteristics of patients who died of coronavirus disease 2019 in China. JAMA Netw Open. 2020;3:e205619. https://doi.org/10.1001/jamanetworkopen.2020.5619
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054-62. https://doi.org/10.1016/S0140-6736(20)30566-3
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323:1574-81. https://doi.org/10.1001/jama.2020.5394
Saavedra-Trujillo CH. Consenso Colombiano de Atención, Diagnóstico y Manejo de la Infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24:1-153. httpa://doi.org/10.22354/in.v24i3.851
Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45-67. https://doi.org/10.1164/rccm.201908-1581ST
Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146:110-8. https://doi.org/10.1016/j.jaci.2020.04.006
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239-42. https://doi.org/10.1001/jama.2020.2648
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA. 2020. https://doi.org/10.1001/jama.2020.12839
Zietz M, Tatonetti NP. Testing the association between blood type and COVID-19 infection, intubation, and death. medRxiv. 2020. https://doi.org/10.1101/2020.04.08.20058073
Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, et al. Relationship between the ABO Blood Group and the COVID-19 Susceptibility. medRxiv. 2020. https://doi.org/10.1101/2020.03.11.20031096
Tamara A, Tahapary DL. Obesity as a predictor for a poor prognosis of COVID-19: A systematic review. Diabetes Metab Syndr. 2020;14:655-9. https://doi.org/10.1016/j.dsx.2020.05.020
Carr E, Bendayan R, Bean D, Stammers M, Wang W, Zhang H, et al. Evaluation and improvement of the National Early Warning Score (NEWS2) for COVID-19: A multi-hospital study. medRxiv. 2020. https://doi.org/10.1101/2020.04.24.20078006
Li Y, Xia L. Coronavirus disease 2019 (COVID-19): Role of chest CT in diagnosis and management. AJR Am J Roentgenol. 2020;214:1280-6. https://doi.org/10.2214/AJR.20.22954
Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology. 2020;296:e32-40. https://doi.org/10.1148/radiol.2020200642
Li Y, Yang Z, Ai T, Wu S, Xia L. Association of “initial CT” findings with mortality in older patients with coronavirus disease 2019 (COVID-19). Eur Radiol. 202. https://doi.org/10.1007/s00330-020-06969-5
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395:507-13. https://doi.org/10.1016/S0140-6736(20)30211-7
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475-81. https://doi.org/10.1016/S2213-2600(20)30079-5
Mehra MR, Ruschitzka F, Patel AN. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis. Lancet. 2020;395:1820. https://doi.org/10.1016/S0140-6736(20)31180-6 Retracted article.
The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with COVID-19 - preliminary report. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2021436
Some similar items:
- Cristian Antony Ramos-Vera, Juan Camilo Motta, Letter to the editor "Prognostic factors in hospitalized patients diagnosed with SARS-CoV-2 infection, Bogotá, Colombia" , Biomedica: Vol. 41 No. 2 (2021)
- Jeison Monroy-Gómez, Orlando Torres-Fernández , Effects of the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) on the nervous system. What can we expect from SARS -CoV-2? , Biomedica: Vol. 40 No. Supl. 2 (2020): SARS-CoV-2 y COVID-19
- Daniele Piovani , Georgios K. Nikolopoulos, Stefanos Bonovas, Pitfalls and perils of survival analysis under incorrect assumptions: the case of COVID-19 data , Biomedica: Vol. 41 No. Sp. 2 (2021): Octubre, Infecciones bacterianas y virales
- Gustavo Aroca, María Vélez-Verbel , Andrés Cadena , Lil Geraldine Avendaño , Sandra Hernández, Angélica Sierra, Omar Cabarcas, Santos Ángel Depine, COVID-19 in hemodialysis patients in Colombia: Report of seven cases , Biomedica: Vol. 40 No. Supl. 2 (2020): SARS-CoV-2 y COVID-19
- Azucena Cabrera , Dubán González-Álvarez , Luz A. Gutiérrez , Francisco J. Díaz, Diego Forero , Juan David Rodas , Natural SARS-CoV- 2 infection in domestic cats and dogs of humans diagnosed with COVID-19 in Valle de Aburrá, Antioquia , Biomedica: Vol. 42 No. Sp. 2 (2022): Covid-19
- Hernán Bayona , María Camila Valencia, Angélica Peña , Natalia Ramírez, Carlos Martínez , Fatal reversible cerebral vasoconstriction syndrome: An unusual presentation of a rare disease , Biomedica: Vol. 41 No. 2 (2021)
- Alfredo G. Torres, Vaccines against SARS-CoV-2: Are they a reality for Latin America? , Biomedica: Vol. 40 No. 3 (2020)
- Alexander Rodríguez, Eliana Cervera, Rafael Tuesca, Karen Flórez, Ricardo Romero, Pedro J. Villalba, The delayed detection of an acute neurological worsening increases traumatic brain injury lethality. , Biomedica: Vol. 40 No. 1 (2020)
- Ignacio Zarante, Liliana Franco, Catalina López, Nicolás Fernández, Frequencies of congenital malformations: assessment and prognosis of 52,744 births in three cities of Colombia , Biomedica: Vol. 30 No. 1 (2010)
- Álvaro J. Ruiz, Pablo J. Aschner, María Fernanda Puerta, Rafael Alfonso-Cristancho, IDEA Study (International Day for the Evaluation of Abdominal Obesity): Primary care study of the prevalence of abdominal obesity and associated risk factors in Colombia , Biomedica: Vol. 32 No. 4 (2012)
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
